"Willkommen im Klinikum Osnabrück, 1811 wurde das Klinikum als Stadtkrankenhaus eröffnet. Heute wird hier die höchste Versorgungsstufe in Medizin, Pflege und Therapie angeboten. Als erstes akademisches Lehrkrankenhaus der Westfälischen Wilhelms-Universität schult das Klinikum seit 1971 den medizinischen Nachwuchs. Die Aus-, Fort- und Weiterbildung aller Mitarbeitenden wird in der hauseigenen Akademie gefördert. Über 2.450 Mitarbeiter haben im Klinikum Osnabrück ihren Arbeitsplatz und betreuen jährlich etwa 34.500 stationäre und 75.000 ambulante Patienten. Rund um die Uhr – 365 Tage im Jahr. Besuchen Sie unsere Homepage."

During the past decade, Klinikum Osnabrück GmbH conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 4 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum Osnabrück GmbH" #1 sponsor was "University Hospital, Essen" with 2 trials, followed by "Boehringer Ingelheim" with 1 trials sponsored, "Charite University, Berlin, Germany" with 1 trials sponsored, "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 1 trials sponsored and "Grifols Therapeutics LLC" with 1 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Osnabrück GmbH" #1 collaborator was "Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)" with 1 trials as a collaborator, "German Center for Neurodegenerative Diseases (DZNE)" with 1 trials as a collaborator, "Johannes Gutenberg University Mainz" with 1 trials as a collaborator, "Medtronic" with 1 trials as a collaborator and "Novotech Health Holdings Pte. Ltd." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Osnabrück GmbH" are "Ischemic Stroke" (2 trials), "Acute Coronary Syndrome" (1 trials), "Acute Ischemic Stroke" (1 trials), "Atrial Fibrillation" (1 trials) and "Avascular Necrosis" (1 trials). Many other conditions were trialed in "Klinikum Osnabrück GmbH" in a lesser frequency.

Most popular intervention types in "Klinikum Osnabrück GmbH" are "Drug" (9 trials), "Device" (3 trials), "Biological" (2 trials), "Other" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "7-day Holter ECG" (1 trials), "ASA 100 mg" (1 trials), "Albumin (Human) 25%, United States Pharmacopeia (USP)" (1 trials), "Bortezomib" (1 trials) and "Coronary angiography" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Osnabrück GmbH" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Klinikum Osnabrück GmbH". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Klinikum Osnabrück GmbH, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Osnabrück GmbH, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".

Klinikum Osnabrück GmbH has several departments that took part in Clinical trials: "Klinikum Osnabrück, Klinik für Neurologie" - 2 trials